Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Non-Current Liabilities ₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr₹6.27 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹10.00 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr
Mar2016₹6.27 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr
23.39
Mar2016 ₹6.27 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,802.0 Cr -10% -2.7% 48.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-10%

-2.7%

48.3%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses